On May 28, 2020 bluebird bio, Inc. (NASDAQ: BLUE) reported that the company will host a live webcast to review new data presented at the European Hematology Association (EHA) (Free EHA Whitepaper) Annual Meeting on Friday, June 12 at 8:00 am ET (Press release, bluebird bio, MAY 28, 2020, View Source [SID1234558634]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors may listen to the call on June 12, 2020 at 8:00 am ET by dialing (844) 825-4408 from locations in the United States or +1 (315) 625-3227 from outside the United States. Please refer to conference ID number 2796099.

In addition, members of the management team will participate in the following upcoming investor conferences:

Jefferies Virtual Healthcare Conference, Thursday, June 4, at 3:30 pm ET
Goldman Sachs 41st Annual Global Healthcare Conference, Wednesday, June 10, at 9:40 am ET
To access the live webcasts of bluebird bio’s presentations, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at View Source Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.